Jan 2014-Global Lifesciences Business in India - News & Updates

Top Highlights for January 2014:  (Please click on read more to see details)

  1. Indian Biotech industry is expecting to achieve revenue of US$ 11.6 billion by the year 2017 
  2. Indian pharma, medical and biotech posted $4.2zbillion M&A deals in 2013 
  3. Goldman Sachs fourth investment in Indian healthcare sector: $47.82 million to acquire 26% of India’s Opto Circuits Read more 
  4. Japan's Arkray to buy India's Span Diagnostics for $15.94 million to scale up its presence in India’s IVD sector 
  5. India's Ranbaxy and Switzerland's Epirus inks licensing pact for a biosimilar product  
  6. Sweden's NovaSAID & India’s Cadila collaborate to develop arthritis drug 
  7. US's Galena Biopharma & India’s Dr. Reddy’s in development & commercialization partnership for NeuVax(TM) in India  Read more 
  8. Advaxis, US & Biocon, India inks a pact for developing a novel cervical cancer immunotherapy
  9. Eli Lilly aims to be among top 20 pharma companies in India by 2020 
×
Twitter